Pol theta inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
View/ Open
Date
2021-12-01ICR Author
Author
Zatreanu, DA
Robinson, HMR
Alkhatib, O
Boursier, M
Finch, H
Geo, L
Grande, D
Grinkevich, V
Heald, R
Langdon, S
Majithiya, J
McWhirter, C
Martin, NMB
Moore, S
Neves, J
Rajendra, E
Ranzani, M
Schaedler, T
Stockley, M
Wiggins, K
Brough, R
Sridhar, S
Gulati, A
Shao, N
Badder, LM
Novo, D
Knight, EG
Marlow, R
Haider, S
Callen, E
Hewitt, G
Schimmel, J
Prevo, R
Alli, C
Ferdinand, A
Bell, C
Blencowe, P
Calder, M
Charles, M
Curry, J
Ekwuru, T
Ewings, K
Nussenzweig, A
Tijsterman, M
Tutt, A
Boulton, SJ
Higgins, GS
Pettitt, S
Smith, GCM
Lord, CJ
Type
Conference Proceeding
Metadata
Show full item recordCollections
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
Language
eng
Date accepted
2021-04-30
License start date
2021-12-01
Citation
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12), pp. ? - ? (3)
Publisher
AMER ASSOC CANCER RESEARCH